$179 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 116.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KURA | Buy | KURA ONCOLOGY INC. COMMON STOCK | $9,834,000 | +29.0% | 536,500 | +13.2% | 5.48% | +53.9% |
XENE | Buy | XENON PHARMACEUTICALS INC | $8,289,000 | +20.5% | 272,500 | +21.1% | 4.62% | +43.7% |
RLMD | Buy | RELMADA THERAPEUTICS INC | $6,694,000 | -27.5% | 352,500 | +3.1% | 3.73% | -13.5% |
MRTX | Buy | MIRATI THERAPEUTICS | $6,344,000 | +47.0% | 94,500 | +80.0% | 3.53% | +75.2% |
ISEE | Buy | IVERIC BIO INC | $5,422,000 | -40.3% | 563,607 | +4.5% | 3.02% | -28.8% |
New | ROCHE GS | $5,338,000 | – | 16,000 | +100.0% | 2.97% | – | |
RCUS | New | ARCUS BIOSCIENCES INC | $4,244,000 | – | 167,500 | +100.0% | 2.36% | – |
DTIL | New | PRECISION BIOSCIENCES INC | $3,281,000 | – | 2,050,359 | +100.0% | 1.83% | – |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $3,063,000 | – | 13,000 | +100.0% | 1.71% | – |
HZNP | Buy | HORIZON THERAPEUTICS PLC | $2,862,000 | -18.1% | 35,888 | +8.1% | 1.59% | -2.3% |
MIST | Buy | MILESTONE PHARMACEUTICALS IN | $2,812,000 | +15.2% | 457,200 | +20.3% | 1.57% | +37.5% |
PMVP | Buy | PMV PHARMACEUTICALS INC | $2,173,000 | -23.0% | 152,500 | +12.5% | 1.21% | -8.1% |
RZLT | New | REZOLUTE INC | $2,084,000 | – | 645,136 | +100.0% | 1.16% | – |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $1,704,000 | -13.9% | 154,356 | +29.9% | 0.95% | +2.6% |
Buy | PYXIS ONCOLOGY INC | $1,535,000 | +90.0% | 645,149 | +222.6% | 0.86% | +126.2% | |
Buy | VENTYX BIOSCIENCES INC | $1,492,000 | +55.1% | 122,000 | +72.1% | 0.83% | +85.1% | |
ENTA | Buy | ENANTA PHARMACEUTICALS INC | $1,300,000 | +692.7% | 27,500 | +1095.7% | 0.72% | +840.3% |
ITOS | New | ITEOS THERAPEUTICS INC | $1,277,000 | – | 62,000 | +100.0% | 0.71% | – |
ACAD | New | ACADIA PHARMACEUTICALS INC | $1,007,000 | – | 71,500 | +100.0% | 0.56% | – |
New | AC IMMUNE SAcall | $354,000 | – | 100,000 | +100.0% | 0.20% | – | |
New | ATHIRA PHARMA INCcall | $340,000 | – | 100,000 | +100.0% | 0.19% | – | |
GOSS | New | GOSSAMER BIO INC | $268,000 | – | 32,000 | +100.0% | 0.15% | – |
SWTX | New | SPRINGWORKS THERAPEUTICS INC | $123,000 | – | 5,000 | +100.0% | 0.07% | – |
TRVI | New | TREVI THERAPEUTICS INC | $98,000 | – | 35,000 | +100.0% | 0.06% | – |
OCUL | New | OCULAR THERAPEUTIX INC | $53,000 | – | 13,171 | +100.0% | 0.03% | – |
NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $25,000 | – | 90,832 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
IRIDEX CORP | 20 | Q3 2019 | 8.1% |
ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
VERACYTE INC | 19 | Q3 2019 | 10.1% |
ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.